| Literature DB >> 35116344 |
Weihan Li1, Chenwei Jiang1, Erhao Zhang1,2.
Abstract
Membraneless organelles (MLOs) are micro-compartments that lack delimiting membranes, concentrating several macro-molecules with a high local concentration in eukaryotic cells. Recent studies have shown that MLOs have pivotal roles in multiple biological processes, including gene transcription, RNA metabolism, translation, protein modification, and signal transduction. These biological processes in cells have essential functions in many diseases, such as cancer, neurodegenerative diseases, and virus-related diseases. The liquid-liquid phase separation (LLPS) microenvironment within cells is thought to be the driving force for initiating the formation of micro-compartments with a liquid-like property, becoming an important organizing principle for MLOs to mediate organism responses. In this review, we comprehensively elucidated the formation of these MLOs and the relationship between biological functions and associated diseases. The mechanisms underlying the influence of protein concentration and valency on phase separation in cells are also discussed. MLOs undergoing the LLPS process have diverse functions, including stimulation of some adaptive and reversible responses to alter the transcriptional or translational processes, regulation of the concentrations of biomolecules in living cells, and maintenance of cell morphogenesis. Finally, we highlight that the development of this field could pave the way for developing novel therapeutic strategies for the treatment of LLPS-related diseases based on the understanding of phase separation in the coming years. 2021 Translational Cancer Research. All rights reserved.Entities:
Keywords: Membraneless organelle (MLO); biological process; cancer; liquid-liquid phase separation (LLPS); micro-compartment
Year: 2021 PMID: 35116344 PMCID: PMC8797891 DOI: 10.21037/tcr-21-1111
Source DB: PubMed Journal: Transl Cancer Res ISSN: 2218-676X Impact factor: 1.241
Figure 1Overview of MLOs in living cells. (A) MLOs formed by LLPS. MLOs are ubiquitous in cells, where inner molecules undergoing liquid-liquid phase separation are concentrated to a higher concentration relative to their surrounding milieu. (B) Molecular characteristics of proteins involved in many liquid-like condensates. Left channel, proteins carrying MIDs are prone to driving phase separation through multivalent interactions of internal components, such as SH2 and SH3 domains of Nck and PRMs of neural Wiskott-Aldrich syndrome protein, as well as multiple repeats of SUMO domains and SIM ligands. Right channel, protein containing a large number of LCDs provides multiple weakly adhesive sequence elements to drive phase separation, including repeated sequence elements (such as FUS and nephrin) and prion-like domains (such as α-helical structures and β-strands). (C) Regulation of phase separation in cellular compartmentalization. In living cells, there are different types of multivalent interactions to facilitate phase separation, which is regulated by several environmental parameters (such as salt concentration, temperature, and pH) and internal parameters (such as protein concentrations and valencies). Specifically, various PTMs of proteins effectively remodel the valency and interaction strength of proteins, thereby tuning the assembly of biomolecular condensates through modulating the process of phase separation. LLPS, liquid-liquid phase separation; MLOs, membraneless organelles; MIDs, modular interaction domains; SH3, Src homology 3; PRMs, proline-rich motifs; SUMO, small ubiquitin-related modifier; SIM, SUMO-interacting motif; LCDs, low complexity domains; FUS, fused in sarcoma; TDP43, TAR DNA-binding protein 43; hnRNPA2, heterogeneous-nuclear ribonucleoprotein group A2; PTMs, post-translational modifications.
Figure 2A schematic of various phase separation-organized MLOs in eukaryotic cells. MLOs produced by LLPS are mainly distributed in the nucleus, nuclear membrane, cytoplasm, and plasma membranes of eukaryotic cells. Specifically, several MLOs, including nucleolus, perinucleolar compartment, paraspeckle, Cajal body, cleavage body, Gem, OPT domain body, nuclear speckle, PcG body, histone locus body, and PML bodies, are mainly produced in the nucleus by the LLPS microenvironment, whereas other MLOs are produced in the nuclear membrane (such as nuclear pore complex), cytoplasm (such as stress granule, P body, U body, Balbina body, germ granule, transport RNP, and synaptic density), and plasma membrane (such as immune synapse, focal adhesion, and podosome). MLOs have multiple biological functions related to various diseases, shown in detail in . OPT, Oct1/PTF/transcription; PcG, polycomb group; PML, promyelocytic leukemia; P body, processing body; U body, uridine-rich snRNPs body; ALS, amyotrophic lateral sclerosis; SMA, spinal muscular atrophy; FTLD, frontotemporal lobar degeneration. MLO, membraneless organelle; LLPS, liquid-liquid phase separation.
Basic characteristics of several MLOs
| Location | MLO name | Defining components | Functions | Diseases |
|---|---|---|---|---|
| Nucleus | Cajal body | Coilin, SMN | Pre-mRNA splicing, pre-rRNA processing | ALS, SMA ( |
| Cleavage body | CstF-64, CPSF-100 | DNA replication, processing | NA | |
| Gem | SMN | Pre-mRNA splicing, RNA metabolism | SMA ( | |
| Nuclear speckle | snRNPs, SR proteins, Malat1 | Gene transcription, RNA processing | NA | |
| Nucleolus | RNA Pol I machinery | rDNA transcription, pre-rRNA processing, ribosome biogenesis | Werner syndrome, Treacher Collins syndrome, dyskeratosis congenita syndrome, Rothmund-Thomson syndrome ( | |
| OPT domain body | PTF, Oct1, TBF, Sp1 | Gene transcription, antiviral defense | NA | |
| PcG body | PRC1, PRC2, PREs | Transcriptional repression, sumoylation centers | Cancer ( | |
| Perinucleolar compartment | CUGBP, KSRP | tRNA maturation, pre-ribosomal RNA processing, mitochondrial DNA replication | Cancer ( | |
| PML body | PML, DNMT3A, Mx1 | DNA replication, transcription, epigenetic gene silencing | Liver fibrosis ( | |
| Histone locus body | NPAT, FLASH | Histone transcription, pre-mRNAs processing | NA | |
| Paraspeckle | CTN-RNA, PSP1, p54nrb | RNA processing | Mammalian development, antiviral defense, cancer ( | |
| Nuclear membrane | Nuclear pore complex | FG-NUPs | Nucleocytoplasmic transport | Cancer ( |
| Cytoplasm | P body | DCP1A, TNRC6A/GW18, DDX6, RAP55, MxA | mRNA metabolism | ( |
| U body | SMN | snRNP metabolism | SMA ( | |
| Balbiani Body | macf1α, rbpms2 | RNA storage | NA | |
| Germ granule | NA | Post-transcriptional regulation | Germ cell development ( | |
| Transport RNP | Staufen1, Staufen2, FMRP, ZBP1, hnRNPA2, CPEB, Pura, and SMN | mRNA transport | NA | |
| Synaptic density | SynGAP, PSD-95 | Signal processing and transmission | Autism, intellectual disability, mental illness ( | |
| Stress granule | RBPs, non-RBPs, TDRD3 | Translational regulation, mRNA storage | ALS, FTLD, some myopathies ( | |
| Plasma membrane | Immune synapse | TCR, NKp46 | Immune synapse rearrangement | NA |
| Focal adhesions | Integrin, talin, paxillin, vinculin, FAK, Mmp1 | Cell migration, proliferation, differentiation | NA | |
| Podosome | actin-rich proteins, actin-associated proteins | Cell adhesion, migration | NA |
MLO, membraneless organelle, NA, not applicable; OPT, Oct1/PTF/transcription; PcG, polycomb group; PML, promyelocytic leukemia; P body, processing body; U body, uridine-rich snRNPs body; ALS, amyotrophic lateral sclerosis; SMA, spinal muscular atrophy; FTLD, frontotemporal lobar degeneration.